|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.040 USD | -1.62% |
|
+10.14% | -16.94% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 101M 88.28M 81.13M 75.62M 143M 9.62B 146M 974M 379M 4.73B 379M 371M 16.29B | P/E 2026 * |
1.27x | P/E 2027 * | 6.02x |
|---|---|---|---|---|---|
| Enterprise Value | 101M 88.28M 81.13M 75.62M 143M 9.62B 146M 974M 379M 4.73B 379M 371M 16.29B | EV / Sales 2026 * |
1.26x | EV / Sales 2027 * | 0.75x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | -1.62% | ||
| 1 week | +10.14% | ||
| Current month | -0.65% | ||
| 1 month | +14.72% | ||
| 3 months | +16.92% | ||
| 6 months | -28.81% | ||
| Current year | -16.94% |
| 1 week | 2.85 |  | 3.2 |
| 1 month | 2.7 | | 3.35 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.77 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 2013-12-19 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 2012-02-21 |
David Jin
DFI | Director of Finance/CFO | 36 | 2022-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 2008-11-30 |
| Chairman | 71 | 2013-12-19 | |
J. Lobell
BRD | Director/Board Member | 63 | 2006-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Free | Chief Financial Officer | 400,000 | 1.2041% | ||
| 03-31 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-17 | Free | Chief Executive Officer | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.62% | +10.14% | +61.70% | -64.75% | 101M | |
| +4.73% | +3.38% | +19.53% | -8.85% | 66.56B | |
| -1.93% | +0.39% | +53.64% | +224.54% | 56.51B | |
| +1.07% | +42.10% | +42.10% | +42.10% | 42.98B | |
| +1.42% | +7.12% | -50.15% | -54.64% | 40.46B | |
| +3.04% | +0.04% | +62.66% | -24.40% | 31.91B | |
| +10.01% | +18.57% | +161.59% | -35.44% | 31.65B | |
| +2.68% | +2.73% | +70.72% | +85.52% | 23.35B | |
| +5.01% | +15.18% | +11.69% | +200.82% | 19.46B | |
| -0.13% | +2.75% | +66.32% | +128.53% | 17.18B | |
| Average | +2.43% | +7.95% | +49.98% | +49.34% | 33.01B | |
| Weighted average by Cap. | +2.67% | +7.31% | +43.16% | +54.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 69.83M 64.17M 59.82M 113M 7.61B 115M 770M 299M 3.74B 300M 293M 12.88B | 134M 117M 108M 100M 191M 12.77B 193M 1.29B 503M 6.28B 504M 493M 21.64B |
| Net income | 90.51M 79.13M 72.72M 67.78M 129M 8.62B 131M 873M 339M 4.24B 340M 332M 14.6B | 21.13M 18.47M 16.98M 15.82M 30.01M 2.01B 30.47M 204M 79.23M 989M 79.32M 77.61M 3.41B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$3.040 | -1.62% | 332,636 |
| 26-07-01 | US$3.090 | +0.98% | 254,656 |
| 26-06-30 | US$3.060 | +3.73% | 490,825 |
| 26-06-29 | US$2.950 | +6.88% | 534,783 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
